Stockreport

Contineum Therapeutics Initiates Patient Dosing in Phase 1b Chronic Pain Trial of PIPE-791 [Yahoo! Finance]

Contineum Therapeutics, Inc. - Common stock  (CTNM) 
PDF SAN DIEGO, March 04, 2025 BUSINESS WIRE )--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering [Read more]